MillionMilesAway
Well-Known Member
Yea I agree
Just think a lot of the PR is different between the Oxford and the rest of them
J&J, Pfizer and Moderna any results always seem to come out with some slick PR release with headline grabbing figures to boost their share price.
Where as the Oxford/Az, certainly at first at least gets people from the Uni making the announcement and some theories on how things could be better etc. Can't help think it would be different if it was the Big Pharma handling the trials and announcements rather than the Uni.
Where are the real world results seem to show no difference between them really. The Oxford one is the one that should be getting all the credit really seeing as it's being distributed at cost etc. Nobel Prize stuff.
Some of that is because AZ have no background in vaccines, and have very few properly qualified people to speak - as far as I know, AZ are providing the power behind the testing, and also the logistics/financial muscle in hooking up with local companies.